Please login to the form below

Not currently logged in
Email:
Password:

Deal Watch March 2017

Medius Deal Watch

Sanofi, MedImmune, AstraZeneca, Astellas, Novartis and more feature in this month's pharma deals round-up

Behaviour Change

BCWInvestigating the science behind behaviour change

Channel strategy and channeling your inner disrupter

Marketing TreeIs this the answer to many of today's marketing challenges?

Making digital health personal

digital health stock resizedWhat makes a tool successfully support adherence and deliver value-based care?

Deal Watch February 2017

Medius Deal WatchActelion, Johnson & Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Webinars

Assessing early market opportunity

To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.

PC: Are you Patient Centric or just Politically Correct?

Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far

Communicating innovation to payers and policy makers

Involving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.

Scale & Strategy: Essential tools for transforming the commercial model

Most life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Video

Webinar: Customer engagement design

Customer engagement design pharma Webinar: Customer engagement design

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

White papers

Can you access your own content?

The rapid development of multichannel communication opens new opportunities to provide high-value experiences for healthcare professionals and gives you more places than ever to tell your product story. But unless

How will capitated budgets affect NHS spending?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the implications of a single budget covering all the physical, mental and social care needs of patients in an STP

Dissecting adherence to personalise patient support

Across the healthcare and pharmaceutical industries, the initiatives to better understand the patient journey and lower healthcare costs have been growing in magnitude. One solution that has repeatedly been raised

A safe place to talk about Crohn’s

Published in eyeforpharma April 2017 by Mariel Metcalfe

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Infographics